Adial Pharmaceuticals (ADIL) Insider Trading & Ownership $1.02 +0.01 (+0.99%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Adial Pharmaceuticals (NASDAQ:ADIL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.24%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$56,318.00Number OfInsiders Selling(Last 3 Years)0 Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADIL Insider Buying and Selling by Quarter Ad Resource Stock DigestThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best names in the lithium space will be set for escalating gains in 2025 and beyond. It’s all being driven by the global EV boom as millions of drivers ditch their gasoline-chugging cars and trucks in favor of lithium-ion-powered vehicles in record numbers. Everything you need to know is in our FREE online lithium report you can get here. Adial Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/29/2023Kevin SchuylerDirectorBuy700$2.74$1,918.00 11/29/2021William B Stilley IIICEOBuy400$64.75$25,900.00 11/26/2021James W Jr. NewmanDirectorBuy400$71.25$28,500.00 (Data available from 1/1/2013 forward) ADIL Insider Trading Activity - Frequently Asked Questions Who is on Adial Pharmaceuticals's Insider Roster? The list of insiders at Adial Pharmaceuticals includes James W Jr. Newman, Kevin Schuyler, and William B Stilley III. Learn more on insiders at ADIL. What percentage of Adial Pharmaceuticals stock is owned by insiders? 5.24% of Adial Pharmaceuticals stock is owned by insiders. Learn more on ADIL's insider holdings. Which Adial Pharmaceuticals insiders have been buying company stock? The following insider purchased ADIL shares in the last 24 months: Kevin Schuyler ($1,918.00). How much insider buying is happening at Adial Pharmaceuticals? Insiders have purchased a total of 700 ADIL shares in the last 24 months for a total of $1,918.00 bought. Adial Pharmaceuticals Key ExecutivesMr. Cary John Claiborne MBA (Age 63)CEO, President & Director Compensation: $728.31kDr. Bankole A. Johnson DSc (Age 64)FRCPsych, M.D., M.Phil, Ph.D., Founder & Chief Medical Officer Compensation: $435kMr. Joseph A. M. Truluck M.B.A. (Age 46)MBA, CFO, Treasurer & Secretary Compensation: $358.49kMr. Tony Goodman (Age 60)COO & Director Compensation: $33kMr. John R. Martin J.D.Chief Legal OfficerMs. Catherine FratilaController More Insider Trading Tools from MarketBeat Related Companies TNXP Insider Transactions EQ Insider Transactions LPCN Insider Transactions BTAI Insider Transactions ATHA Insider Transactions GOVX Insider Transactions XCUR Insider Transactions CVKD Insider Transactions CMMB Insider Transactions ACXP Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ADIL) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADIL Stock Alerts